🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.

Some professionals stated the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

Based on TikTok, the service has taken down violative content and banned related keywords and query recommendations. The company stated it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Online Trading Operations

Research also found communities with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, positive testimonials and step-by-step guides for preparing or administering at residence.

After minutes of joining one community, a seller shared contact information, where most purchases occur. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, health issues or past usage.

Product Information and Pricing

Within these communities, posts display dark colored parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram stated it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to possibly significant medical dangers”.